C07K 14/40
From candida
Official title: from Candida
C07K14/40 (From candida) appears on 139 US grants and 160 published applications in this corpus.
Search patents in C07K- Granted patents
- 139
- Published applications
- 160
- Assignees
- 99
- Inventors
- 333
- Latest grant
- 10 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 5 | 0 |
| 2001 | 10 | 1 |
| 2002 | 15 | 12 |
| 2003 | 7 | 22 |
| 2004 | 7 | 16 |
| 2005 | 4 | 8 |
| 2006 | 9 | 9 |
| 2007 | 6 | 9 |
| 2008 | 7 | 6 |
| 2009 | 3 | 12 |
| 2010 | 6 | 7 |
| 2011 | 7 | 3 |
| 2012 | 1 | 8 |
| 2013 | 4 | 2 |
| 2014 | 7 | 7 |
| 2015 | 2 | 4 |
| 2016 | 3 | 4 |
| 2017 | 1 | 4 |
| 2018 | 6 | 3 |
| 2019 | 0 | 4 |
| 2020 | 2 | 4 |
| 2021 | 4 | 2 |
| 2022 | 2 | 6 |
| 2023 | 1 | 0 |
| 2024 | 2 | 3 |
| 2025 | 2 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treatment for Candida auris infections10 Jun 2025US 12,324,830 B2
- Steviol glycoside transport29 Apr 2025US 12,285,033 B2Dsm IP Assets B.V.
- Steviol glycoside transport12 Mar 2024US 11,925,193 B2Dsm IP Assets B.V.
- Candida tropicalis strain having improved tolerance to the cytotoxicity of substrates, and method for producing dicarboxylic acid using same16 Jan 2024US 11,873,517 B2Korea University Research and Business Foundation
- Vaccine compositions and methods of using the same25 Jul 2023US 11,707,511 B2Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Immunogenic peptides of fungal pathogens and uses thereof20 Aug 2026US 2026/0240965 A1University of Georgia Research Foundation, Inc.
- Adaptation and process optimization of microorganisms for growth in hemicellulosic derived carbohydrates26 Mar 2026US 2026/0085280 A1Mara Renewables Corporation
- Methods of treatment for candida auris infections28 Aug 2025US 2025/0268998 A1
- Antibodies and methods for generating the same6 Mar 2025US 2025/0074972 A1
- Antibodies against candida albicans proteins and their therapeutic and prophylactic use for treating and preventing invasive fungal infections24 Oct 2024US 2024/0352099 A1
Most cited
By later US patents
- Fungal stress proteins26US 5,288,639 AThe Victoria University of Manchester · 1994
- Inhibition of transglutaminase-mediated microbial interaction with a mammalian host24US 6,388,056 B12002
- Identification of Candida cell surface proteins and their uses21US 7,241,613 B1Oscient Pharmaceuticals Corporation · 2007
- Oligonucleotides inhibiting candida germ tube formation18US 5,691,461 AIsis Pharmaceuticals, Inc. · 1997
- Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto17US 6,331,420 B12001